Sunder Biomedical Tech Co (ROCO:4115) Other Financing: NT$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4115 Sunder Biomedical Tech Co Ltd ROCO:4115
52 GF Score
Price NT$7.84
GF Value NT$10.70
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sunder Biomedical Tech Co Other Financing?

Sunder Biomedical Tech Co ROCO:4115 +4.12% 52 Other Financing is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:4115 with a GF Score™ of 52/100 and a GF Value™ of NT$10.70 (Possible Value Trap). The stock has 4 warning signs investors should review.

Sunder Biomedical Tech Co's Other Financing for the six months ended in Dec. 2025 was NT$0.0 Mil.

Sunder Biomedical Tech Co's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.0 Mil.

Sunder Biomedical Tech Co Other Financing Historical Data

* Premium members only.

The historical data trend for Sunder Biomedical Tech Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunder Biomedical Tech Co Other Financing Chart

Sunder Biomedical Tech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial 0.01 0.58 -0.86 0.01 0.00

Sunder Biomedical Tech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.08 0.01 0.00 0.00 0.00
ROCO:4115
52GF Score
Sunder Biomedical Tech Co Ltd ROCO:4115
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunder Biomedical Tech Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of NT$0.0 Mil mean?
Sunder Biomedical Tech Co (ROCO:4115) has a Other Financing of NT$0.0 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sunder Biomedical Tech Co and its competitors.
Is Sunder Biomedical Tech Co's Other Financing too high?
Sunder Biomedical Tech Co's current Other Financing is NT$0.0 Mil. Overall, Sunder Biomedical Tech Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's Other Financing compare to ISRG and BDX?
Sunder Biomedical Tech Co's Other Financing of NT$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sunder Biomedical Tech Co and its competitors. Sunder Biomedical Tech Co's current Other Financing is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Possible Value Trap. The stock's GF Value™ is NT$10.70, compared to a current price of NT$7.84 — trading 26.7% below its estimated fair value. The current Other Financing is NT$0.0 Mil. Sunder Biomedical Tech Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current Other Financing is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?

Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued. The current stock price of NT$7.84 is trading 26.7% below its estimated GF Value™ of NT$10.70. GuruFocus considers Sunder Biomedical Tech Co to be Possible Value Trap.

Key valuation signals for ROCO:4115:

  • Other Financing: NT$0.0 Mil
  • GF Value™: NT$10.70 vs. price of NT$7.84 (26.7% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunder Biomedical Tech Co Business Description

Address No. 1-67, Zhongzheng Road, Chung-Ming Village, Pao-Chung Hsiang, Yunlin, TWN, 63441
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
52GF Score

Get the complete analysis for ROCO:4115

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.84
Price
NT$10.70
GF Value